comparemela.com
Home
Live Updates
Ori Biotech raises over $100 million in Series B funding to
Ori Biotech raises over $100 million in Series B funding to
Ori Biotech raises over $100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform
LONDON, Jan. 18, 2022 /PRNewswire/ -- Ori Biotech Ltd. (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, today announces it...
Related Keywords
London ,
City Of ,
United Kingdom ,
Farlan Veraitch ,
Bruce Levine ,
Stuart Milne Cytiva ,
Anthony Davies ,
Jason Jones Miltenyi ,
Abu Dhabi ,
Barry Clare ,
Lee Unroe Indivior ,
Paul Meister Thermofisher ,
Paul Meister ,
Robert Preti ,
Chris Mason ,
Kevin Gordon Tmunity ,
Jasonc Foster ,
Jasonc Foster Indivior ,
Tom Heathman Minaris ,
Novalis Lifesciences ,
Neil Hunter Michelle Boxall ,
David Smith Minaris ,
Lightspeed Early Access Program ,
Academic Medical Centers ,
Ori Biotech Ltd ,
Image Box Communications ,
Ori Biotech ,
Puhua Capital ,
Chimera Abu Dhabi ,
Amadeus Capital Partners ,
Delin Ventures ,
Northpond Ventures ,
Octopus Ventures ,
Lori Board ,
Novalis Lifesciences Investments ,
Chief Scientific Officer Farlan ,
London And New Jersey Based ,
Annalisa Jenkins ,
Dimension Therapeutics ,
Life Science ,